Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Cash from Financing Activities (2022 - 2025)

Prokidney (PROK) has disclosed Cash from Financing Activities for 4 consecutive years, with $8.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities rose 78.66% to $8.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.1 million, a 94.02% decrease, with the full-year FY2024 number at $144.4 million, up 1611.97% from a year prior.
  • Cash from Financing Activities was $8.0 million for Q3 2025 at Prokidney, up from -$14000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $507.5 million in Q3 2022 to a low of -$9.5 million in Q4 2023.
  • A 4-year average of $46.1 million and a median of -$8000.0 in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: plummeted 118800.0% in 2023, then soared 1075807.69% in 2024.
  • Prokidney's Cash from Financing Activities stood at -$8000.0 in 2022, then tumbled by 118800.0% to -$9.5 million in 2023, then soared by 101.29% to $123000.0 in 2024, then skyrocketed by 6372.36% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Cash from Financing Activities are $8.0 million (Q3 2025), -$14000.0 (Q2 2025), and -$12000.0 (Q1 2025).